Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ranbaxy gets approval for cefprozil in Canada
Cefprozil tablets and powder for oral suspension are indicated for the treatment of upper respiratory tract infections, uncomplicated skin and urinary tract infections. Cefprozil tablets were approved in
Cefprozil tablets and powder for oral suspension are indicated for the treatment of upper respiratory tract infections, uncomplicated skin and urinary tract infections. Cefprozil tablets were approved in
In the first study, healthy volunteers are being immunized with a human version of an alphavaccine that was shown to be effective in protecting against congenital cytomegalovirus disease
The FDA is extending the review of the drug by three months to July 16, 2007. This is in order to provide time for review of an amendment
The primary endpoint of the study is change in glycated hemoglobin (HbA1c) between placebo and treatment groups. The study is also evaluating effects on metabolic and liver function
The drug, R788, is currently being evaluated in immune thrombocytopenic purpura (ITP), rheumatoid arthritis (RA) and lymphoma patients. Rigel said that based on these initial results, it has
Genaera said it will reduce its workforce by approximately 30% over the next three months. The company had already announced job cuts in January after terminating the development
Mylan has requested for a temporary restraining order in its lawsuit seeking to stop the FDA from approving any other generic versions of Norvasc, known as amlodipine besylate.
The company recently filed a special protocol assessment with the FDA for the design of its phase III trial of Xyotax for women with advanced non-small cell lung
Influenza vaccines are usually produced in embryonated hen's eggs. However, there are disadvantages to this process as the eggs require specialized manufacturing facilities that are difficult to scale
The study was conducted by the Southwest Oncology Group (SWOG), a cancer center network sponsored by the National Cancer Institute. SWOG will engage with ImClone and Bristol-Myers Squibb